Northwire Canada EditionSaturday, July 18, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 114
  1. Oct 23, 2025 · 18:28 · QNTM

    Quantum Biopharma licensee Unbuzzd to host webinar

    Quantum Biopharma licensee Unbuzzd to host webinar

    01
  2. Oct 23, 2025 · 17:19 · PNGA

    Pangea's Amino forms collab with U of A scientists

    Pangea's Amino forms collab with U of A scientists

    02
  3. Oct 23, 2025 · 17:12 · MDNA

    Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

    Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

    03
  4. Oct 23, 2025 · 13:26 · BNXT

    Bionxt reiterates BNT23001 dosing optimization study

    Bionxt reiterates BNT23001 dosing optimization study

    04
  5. Oct 23, 2025 · 10:21 · NURS

    Hydreight's Oct. 22 cash at $18.7-million

    Hydreight's Oct. 22 cash at $18.7-million

    05
  6. Oct 23, 2025 · 08:00 · PNGA

    Amino Innovations Forms Strategic Research Partnership with University of Alberta Scientists to Advance Peptide Innovation

    Amino Innovations Forms Strategic Research Partnership with University of Alberta Scientists to Advance Peptide Innovation

    06
  7. Oct 23, 2025 · 05:29 · BNXT

    BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug

    BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug

    07
  8. Oct 23, 2025 · 05:15 · NURS

    Hydreight Reports Corporate Update and Ranks #25 on Deloitte's 2025 Technology Fast 50(TM)

    Hydreight Reports Corporate Update and Ranks #25 on Deloitte's 2025 Technology Fast 50(TM)

    08
  9. Oct 22, 2025 · 20:00 · GSD

    Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units

    Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units

    09
  10. Oct 22, 2025 · 18:55 · SEGN

    Seegnal to release MetricsGuard in Q4 2025

    Seegnal to release MetricsGuard in Q4 2025

    10
  11. Oct 22, 2025 · 16:51 · BCT

    Briacell's Bria-IMT study receives no safety concerns

    Briacell's Bria-IMT study receives no safety concerns

    11
  12. Oct 22, 2025 · 10:58 · FNDX

    Fendx Technologies files patent application in U.S.

    Fendx Technologies files patent application in U.S.

    12
  13. Oct 22, 2025 · 10:31 · SEGN

    Seegnal Inc. Announces the Release of Its New "MetricsGuard" Clinical Decision Support Module

    Seegnal Inc. Announces the Release of Its New "MetricsGuard" Clinical Decision Support Module

    13
  14. Oct 22, 2025 · 10:04 · HEM

    Hemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42

    Hemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42

    14
← Newer Older →